Open access peer-reviewed chapter

Effect of Uropathogenic Escherichia coli on Human Sperm Function and Male Fertility

By Juana V. Villegas, Rodrigo Boguen and Pamela Uribe

Submitted: May 11th 2016Reviewed: March 3rd 2017Published: July 12th 2017

DOI: 10.5772/intechopen.68312

Downloaded: 281


Infections of the reproductive tract represent nearly 15% of male infertility cases. The most frequently isolated bacterium in the ejaculate of infertile men is Escherichia coli (E. coli), which causes between 60 and 85% of cases of chronic bacterial prostatitis leading to sperm damage. The aim of this chapter is to discuss the negative effects of E. coli on sperm quality and male fertility. The E. coli isolated from semen is uropathogenic (UPEC) and can damage sperm in different ways. UPEC induces activation of polymorphonuclear leukocytes with the release of cytokines and reactive oxygen species, the latter being harmful due to their ability to induce lipid peroxidation and early sperm capacitation. Also, UPEC decreases sperm motility, vitality and mitochondrial membrane potential through direct contact or mediated by its soluble metabolites. The negative effects are higher with strains with specific characteristics such as hemolytic capacity. In vivo studies with mice models have shown that UPEC inoculated into the epididymis induces inflammatory damage with testicular mass decrease and low sperm concentration. Future studies are needed to clarify the molecular mechanisms by which E. coli damages sperm. This knowledge will make it possible to take measures to avoid deleterious consequences on the fertilizing potential of men.


  • sperm motility
  • mitochondrial function
  • reactive oxygen species
  • infertility

1. Introduction

Infertility is currently a highly prevalent disease, defined by the failure to achieve a successful pregnancy after 12 months or more of appropriate, unprotected intercourse or therapeutic donor insemination [1]. Approximately 50% of infertility cases are attributed to the male [2, 3] due to conditions such as varicocele, cryptorchidism, obstructive problems, hormonal disorders, ejaculatory dysfunction as well as infectious causes classified under male genital tract infection (MGTI).

MGTI accounts for 15% of male infertility cases [4]. MGTIs are an important problem in male reproductive health because they cause negative changes in semen parameters [5]. A consequence of MGTI is the inflammatory response evidenced by leukocytospermia, where a treatment with antibiotics and anti‐inflammatory drugs may be helpful to try to recover the patient’s fertilizing potential [6]. Principal causes of MGTI are bacteria such as Staphylococcus epidermidis, Streptococcus viridans, Staphylococcus aureus and Escherichia coli (E. coli), which have a negative effect on the fertilizing potential of a man and are strongly associated with MGTI [7, 8]. However, E. coli has been shown to exert greater damaging effects on human spermatozoa [7, 911].

E. coli is the causal agent in 65–80% of cases of chronic bacterial prostatis [12], and these bacteria have been isolated from semen in 69% of the patients with this pathology [13]. Moreover, E. coli causes diverse MGTIs such as urethritis, epididymitis and orchitis, and it is the most frequently isolated bacterium [4].

With this background, this chapter discusses the negative effect of E. coli on sperm quality and male fertility. The chapter will be developed by first addressing the uropathogenic E. coli strains associated with male infertility. Then, the evidence of the in vitro effects of E. coli on the male gamete will be analyzed. Evidences will be described, obtained after in vitro co‐incubation of normal human spermatozoa with E. coli and with polymorphonuclear leukocytes, emulating infection. Next, the effects of E. coli on human sperm functions observed by direct incubation of spermatozoa with bacteria and without leukocytes will be discussed. Also, evidence of the effects of the metabolic and soluble products of E. coli on human sperm function will be analyzed. To complete the picture of the evidence of the effects of this bacterium on male fertility, some studies on animal models will be reviewed.

2. Uropathogenic strains of E. coli are associated with male infertility

Among the different pathogenic strains of E. coli, the uropathogenic strains are mainly associated with urinary tract infections (UTI). The pathogenic E. coli is classified according to the O antigens. Some of these have been associated with uropathogenic E. coli (UPEC) being the serotypes O1, O2, O4, O6, O7, O8, O16, O18, O25, and O75 preferentially associated with these strains [14]. Similarly, the most frequently O antigens associated among the serotypes isolated from patients with prostatitis are O1, O2, O4, O16, O18, O22, O25 and O75 serotypes [15], which coincide with E. coli strains isolated in cases of infections to the urinary tract. Regarding to the strains isolated from semen of infertile men, the described prevalent antigens are O1, O2, O4 and O6 [16]. These data indicate that the E. coli that infects the male reproductive tract is uropathogenic strain, which is not surprising considering the proximity of the urinary and reproductive tracts.

3. Effect of E. coli on human spermatozoa is induced through seminal leukocytes

One way E. coli induces damage in spermatozoa is by mediating seminal leukocyte activation. The increased presence of leukocytes in semen, known as leukocytospermia, is defined by a concentration equal to or greater than 1 x 106 leukocytes per ml of semen [17]. Proinflammatory cytokines, which are usually released by leukocytes during the inflammatory response, are able to decrease sperm motility by themselves [5, 18, 19]. This damaging effect seems to be mediated by polymorphonuclear (PMN) leukocytes instead of by other leukocytes such as lymphocytes or monocytes [20]. The decrease in sperm quality is also mediated by reactive oxygen species (ROS) released by PMN after bacteria‐induced activation, with E. coli being able to induce a higher response of increased ROS production than other bacteria [9]. Other consequences of ROS released by leukocytes are lipid peroxidation, which affects sperm plasma membrane [21, 22], and early induction of sperm capacitation, which should normally occur later in the female reproductive tract [23].

4. E. coli directly affects human sperm function

The direct effect of E. coli on sperm was demonstrated through in vitro studies performed by directly incubating both cells. It has been demonstrated by several authors that E. coli coming into contact with spermatozoa causes decreased sperm motility [7, 2426]. The decrease in sperm motility due to E. coli has been attributed for many years to an agglutinating effect on sperm [27]. Sperm agglutination can be caused by bacterial type 1 and P fimbriae; specifically, the type 1 fimbriae of E. coli cause a pattern of head‐head type agglutination because they bind mannose residues in the head region of sperm. Instead, type P fimbriae of E. coli cause a head‐tail agglutination pattern because they bind gal‐gal receptors present along the sperm [28].

Electron microscopy has revealed that this bacterium causes damage primarily in the head of spermatozoa, such as rupture of the plasma membrane, vesicle formation and rupture of the inner and outer membranes of the acrosome [29].

Consistent with the plasma membrane damages observed, another report showed that E. coli per se causes phosphatidylserine translocation, a cell death indicator [9]. From the point of view of sperm cell death, it was observed that E. coli endotoxins such as lipopolysaccharide (LPS), peptidoglycan and porins produce loss of sperm viability [30]. Moreover, it has been shown that LPS and porins cause sperm DNA fragmentation [31]. The effects of these endotoxins are mediated by the toll‐like receptor (TLR)‐2 and TLR‐4, both present in sperm. After TLR‐2 and TLR‐4 stimulation, sperm damage highlighting DNA fragmentation can be observed [32].

Another direct effect of E. coli is at the level of mitochondrial membrane potential (ΔΨm). The in vitro observation that contact with E. coli decreases the ΔΨm together with the motility in spermatozoa [33] was followed by another report showing, also in vitro, that E. coli directly reduces sperm ΔΨm and alters plasma membrane stability [34]. From the point of view of sperm function, it has been observed that ΔΨm is positively correlated with sperm motility in vivo [35, 36]. However, after contact with some strains of E. coli, which decrease sperm motility in vitro, they had no effect on ΔΨm [37]. This study also found that some E. coli isolated from different patients was unable to decrease sperm motility, remarkably even an O6, which is thought to be a highly uropathogenic strain in urinary tract infections [38]. These facts contrast with the notion that E. coli in general alters sperm function. These differences could be attributed to the fact that different strains bear specific but different characteristics from other E. coli strains. Evidence confirming this was observed in our work, when sperm were incubated with a hemolytic strain of E. coli. This strain caused a decrease in motility, ΔΨm, vitality and an increase in intracellular ROS in normal spermatozoa. These effects were not observed with other strains non‐hemolysis producers [39]. These differences among strains highlight the importance of knowing what kind of toxins are effectively produced by the E. coli strain infecting a patient, because it could indicate the level of sperm damage to be expected. As example, hemolytic E. coli strains produce the alpha‐hemolysin (HlyA) toxin [40], a calcium‐dependent pore‐forming toxin which has intracellular effects, inactivating pathways related to cell survival [41]. This toxin can be highly relevant, particularly if we consider that between 40 and 50% of E. coli strains isolated from patients with epididymitis release this toxin [42].

Evidence of E. coli effects on human spermatozoa shows that this bacterium impairs sperm quality, principally causing decreased motility; nevertheless, there are other consequences for sperm quality, specifically the incubation of sperm with E. coli decreases the ability of the male gamete to penetrate the oocyte, the most important step in the function of the spermatozoon [43].

5. Soluble products of E. coli also affect human sperm function

The effects of E. coli soluble products on sperm have been studied using supernatants of E. coli culture as a source of bacterial metabolic product. It has been reported that although the direct contact with E. coli was able to alter sperm motility, the metabolic products of E. coli had no effect on decreasing motility in human spermatozoa [24]. However, after this report, it was shown that incubation with the soluble factors of E. coli reduced sperm motility and ΔΨm [33]. Added to this, the ability of E. coli soluble factors to decrease motility, viability, ΔΨm and increase ROS in spermatozoa can be prevented by lactobacilli. In an in vitro experiment, after adding lactobacilli to simulate the normal condition in the female genital tract, the harmful effects of E. coli soluble factors were inhibited [44].

Among the soluble factors of E. coli, a component called spermatozoa immobilization factor (SIF) was first described in 1977. The effect of SIF, as the name implies, is to immobilize spermatozoa, and this effect could be reversed by washing the spermatozoa [45]. Years later, an apparently similar SIF of 56 kDa was isolated and purified from supernatants of a strain of E. coli. SIF‐56 decreases sperm motility completely and almost instantaneously. It was also observed that SIF‐56 at very high concentrations can even induce sperm death [46]. Sperm immobilization mediated by SIF‐56 has been shown to depend on 115 kDa‐receptor present in sperm [47]. Another E. colisoluble factor described is the sperm agglutinating factor (SAF) of 71 kDa, which produces sperm agglutination, decreases ATPase activity and can cause sperm death [48]. A toxin candidate to be further investigated is HlyA, because this toxin is produced by E. coli strains most pathogenic to sperm both in vitro and in vivo [42].

6. Animal model research

In vitro investigations have the disadvantage of not necessarily representing what would happen in vivo. Hence, in vivo studies in animal models allow us to get closer to the reproductive reality of a man with accessory glands infected by E. coli. That is how the progressive reduction of testicular size with a consequent decrease in sperm count caused by the necrotic death of the testicular germ cell has been described in rats inoculated with E. coli [49]. After three days of injecting rats with HlyA producing E. coli, the epididymis had epithelial damage, leukocyte infiltration and edema and the sperm‐fertilizing potential was lost, because despite being motile, the spermatozoa had a premature acrosome reaction [50]. The above‐mentioned greater pathogenicity of the HlyA‐producing E. coli strains was reported in the work of Lang [50], where the E. coli strains that did not produce HlyA induced only slight damage to the epididymis. As already stated, sperm recognize peptidoglycans and LPS through TLR‐2 and TLR‐4, and this recognition event induces sperm cell death. This was confirmed by using knockout mice for both TLR‐2 and ‐4 and by observing that in these animals LPS or peptidoglycans did not induce sperm death [32].

Further evidence of the contribution of some E. coli strains to infertility was observed after inoculating the vaginal tract of rats with SAF‐producing strains. Control rats were inoculated with E. coli non‐SAF producers. It was observed that the rats inoculated with SAF-producing strains were incapable of pregnancy, demonstrating that these toxin‐producing strains affect fertility profoundly [51].

7. Conclusion

It is clear that E. coli has an important role in causing male infertility associated with genital tract infections. The main mechanism postulated for male infertility by E. coli is the profound damage to different sperm processes and function, either by direct contact and/or through secreted toxins.

While today there is a consensus that E. coli is an important causal agent of MGTI that may actually cause infertility, from the latest evidence presented above, it is clear that this would not be completely true for all UPEC. Due to these differences among the various strains, it seems important to develop molecular studies that can clarify what specific features of the E. coli strains are associated with the pathogenic effects on sperm or with an aggressive inflammatory response this point should be followed.

To date, there have only been a few studies at the molecular level to try to explain how E. coli causes infertility.

Knowledge of the molecular mechanisms by which E. coli damages sperm will make it possible to take measures to avoid its consequences on the fertilizing potential of men.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Juana V. Villegas, Rodrigo Boguen and Pamela Uribe (July 12th 2017). Effect of Uropathogenic <i>Escherichia coli</i> on Human Sperm Function and Male Fertility, <i>Escherichia coli</i>, Amidou Samie, IntechOpen, DOI: 10.5772/intechopen.68312. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

281total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Antimicrobial Mechanisms of Escherichia coli

By Wanda C. Reygaert

Related Book

First chapter

The Phylogeny and Classification of Anopheles

By Ralph E. Harbach

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us